Patents by Inventor Bie Maria Pieter Verbist

Bie Maria Pieter Verbist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group
    Patent number: 9284303
    Abstract: The present invention is related to novel benzimidazole compounds of formula (I) having cannabinoid receptor agonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals, in particular humans.
    Type: Grant
    Filed: August 6, 2013
    Date of Patent: March 15, 2016
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Henricus Jacobus Maria Gijsen, Michel Anna Jozef De Cleyn, Michel Surkyn, Bie Maria Pieter Verbist
  • BENZIMIDAZOLE CANNABINOID AGONISTS BEARING A SUBSTITUTED HETEROCYCLIC GROUP
    Publication number: 20130324529
    Abstract: The present invention is related to novel benzimidazole compounds of formula (I) having cannabinoid receptor agonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals, in particular humans.
    Type: Application
    Filed: August 6, 2013
    Publication date: December 5, 2013
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Henricus Jacobus Maria Gijsen, Michel Anna Jozef De Cleyn, Michel Surkyn, Bie Maria Pieter Verbist
  • Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group
    Patent number: 8524757
    Abstract: The present invention is related to novel benzimidazole compounds of formula (I) having cannabinoid receptor agonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals, in particular humans.
    Type: Grant
    Filed: July 2, 2007
    Date of Patent: September 3, 2013
    Assignee: Janssen Pharmaceutica NV
    Inventors: Henricus Jacobus Maria Gijsen, Michel Anna Jozef De Cleyn, Michel Surkyn, Bie Maria Pieter Verbist
  • Equilibrative nucleoside transporter ENT1 inhibitors
    Patent number: 8263592
    Abstract: The present invention is related to novel compounds of formula (I) having equilibrative nucleoside transporter ENT1 inhibiting properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the inhibition of ENT1 receptors in animals, in particular humans.
    Type: Grant
    Filed: November 13, 2008
    Date of Patent: September 11, 2012
    Assignee: Janssen Pharmaceutica NV
    Inventors: Jean-Paul René Marie André Bosmans, Didier Jean-Claude Berthelot, Serge Maria Aloysius Pieters, Bie Maria Pieter Verbist, Michel Anna Jozef De Cleyn
  • EQUILIBRATIVE NUCLEOSIDE TRANSPORTER ENT1 INHIBITORS
    Publication number: 20100280025
    Abstract: The present invention is related to novel compounds of formula (I) having equilibrative nucleoside transporter ENT1 inhibiting properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the inhibition of ENT1 receptors in animals, in particular humans.
    Type: Application
    Filed: November 13, 2008
    Publication date: November 4, 2010
    Inventors: Jean-Paul R.M.A. Bosmans, Didier Jean-Claude Berthelot, Serge Maria Aloysius Pieters, Bie Maria Pieter Verbist, Michel Anna Jozef De Cleyn
  • FLUORO ALKYL SUBSTITUTED BENZIMIDAZOLE CANNABINOID AGONISTS
    Publication number: 20100273831
    Abstract: The present invention is related to novel benzimidazole compounds of formula (I) having cannabinoid receptor agonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals, in particular humans.
    Type: Application
    Filed: December 16, 2008
    Publication date: October 28, 2010
    Inventors: Henricus Jacobus Maria Gijsen, Bie Maria Pieter Verbist, Michel Surkyn
  • BENZIMIDAZOLE CANNABINOID AGONISTS BEARING A SUBSTITUTED HETEROCYCLIC GROUP
    Publication number: 20090312339
    Abstract: The present invention is related to novel benzimidazole compounds of formula (I) having cannabinoid receptor agonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals, in particular humans.
    Type: Application
    Filed: July 2, 2007
    Publication date: December 17, 2009
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Henricus Jacobus Maria Gijsen, Michel Anna Jozef De Cleyn, Michel Surkyn, Bie Maria Pieter Verbist